Conferences
ESMO 2017: Prostate Cancer Poster Discussion: Invited Discussant
September 13, 2017
ESMO 2017: Urothelial Carcinoma Poster Discussion – Invited Discussant
September 13, 2017
ESMO 2017: Biological assessment of viable germ cell tumor in patients with seminoma and non-seminoma using miR371
September 13, 2017
ESMO 2017: SPAZO2 (SOGUG): Comparative effectiveness of everolimus vs axitinib as second-line after first-line pazopanib in metastatic renal carcinoma
September 12, 2017
ESMO 2017: Cabozantinib for the treatment of patients with metastatic variant histology renal cell carcinoma: A retrospective study
September 12, 2017
ESMO 2017: Real World Treatment Costs and Resource Utilization among Patients with Metastatic Bladder Cancer
September 12, 2017
ESMO 2017: The prognostic role of neutrophil-to-lymphocyte ratio in patients with metastatic germ cell tumors
September 12, 2017